Abbott, Neurocrine Biosciences to commercialize elagolix Patient enrollment complete for lung cancer treatment trial Horizon: Lodotra reduces RA symptoms in patients in trial GSK's Traber to lead FDA approval process for Pro-Pharmaceuticals drug Immunomedics starts milatuzumab trial Decision Resources projects blockbuster sales for Gilenia Genzyme's Campath gets fast-track designation from FDA Teva's investment in Andromeda will fund diabetes treatment Bayer, Onyx: Nexavar fails in lung cancer study FDA advisory committee gives nod to investigational MS drug First Previous 190 191 192 193 194 Next Last